Regeneron Pharmaceuticals Inc. sell robertinio
Start price
20.04.20
/
50%
€534.90
Target price
01.05.20
-
Performance (%)
-9.33%
End price
01.05.20
€485.00
Summary
This prediction ended on 01.05.20 with a price of €485.00. With a performance of -9.33%, the SELL prediction for Regeneron Pharmaceuticals Inc. by robertinio was down slightly. robertinio has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.927% | -1.927% | -7.153% | -2.250% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% | 64.694% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% | 109.729% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% | 55.832% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% | 67.674% |
Comments by robertinio for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Sell Regeneron Pharmaceuticals Inc.